A tough week for MDMA-assisted psychotherapy

Off Biotech, biotechnology, Business, drug development, drug prices, Human Health, Life Sciences, Medicine, Pharma, research, Science and Research, The Readout

Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox.

Morning. A hard weekend for those backing MDMA-assisted psychotherapy: First, the FDA rejects a treatment from Lykos Therapeutics. Now a journal is retracting three MDMA papers, citing data integrity issues. Also, a nasal epinephrine spray gets an FDA approval, and more.

Read the rest…

Read Original Article: A tough week for MDMA-assisted psychotherapy »

About The Author